Journal of Medical Genetics · 2013 · 245 citations · 88 references
Life SciencesCardiologyGeneticsCardiovascular GeneticsGenomicsMedical GeneticsCardiovascular GenomicsHypertrophic Cardiomyopathy GeneticsRare Variant AnalysisVariant AnalysisVariant DetectionVariant InterpretationCardiomyopathy GenomicsDiagnostic Variant InterpretationHereditary Cardiovascular Variant InterpretationHypertrophic Cardiomyopathy ScreeningInherited Cardiac Disease DetectionNext-generation Sequencing In CardiomyopathyRare Genetic VariantsSingle-nucleotide Polymorphisms
BACKGROUND: Clinical interpretation of the large number of rare variants identified by high throughput sequencing (HTS) technologies is challenging. The aim of this study was to explore the clinical implications of a HTS strategy for patients with hypertrophic cardiomyopathy (HCM) using a targeted HTS methodology and workflow developed for patients with a range of inherited cardiovascular diseases. By comparing the sequencing results with published findings and with sequence data from a large-scale exome sequencing screen of UK individuals, we sought to quantify the strength of the evidence supporting causality for detected candidate variants. METHODS AND RESULTS: 223 unrelated patients with HCM (46±15 years at diagnosis, 74% males) were studied. In order to analyse coding, intronic and regulatory regions of 41 cardiovascular genes, we used solution-based sequence capture followed by massive parallel resequencing on Illumina GAIIx. Average read-depth in the 2.1 Mb target region was 120. Rare (frequency<0.5%) non-synonymous, loss-of-function and splice-site variants were defined as candidates. Excluding titin, we identified 152 distinct candidate variants in sarcomeric or associated genes (89 novel) in 143 patients (64%). Four sarcomeric genes (MYH7, MYBPC3, TNNI3, TNNT2) showed an excess of rare single non-synonymous single-nucleotide polymorphisms (nsSNPs) in cases compared to controls. The estimated probability that a nsSNP in these genes is pathogenic varied between 57% and near certainty depending on the location. We detected an additional 94 candidate variants (73 novel) in desmosomal, and ion-channel genes in 96 patients (43%). CONCLUSIONS: This study provides the first large-scale quantitative analysis of the prevalence of sarcomere protein gene variants in patients with HCM using HTS technology. Inclusion of other genes implicated in inherited cardiac disease identifies a large number of non-synonymous rare variants of unknown clinical significance.
88
The Sequence Alignment/Map format and SAMtools
Heng Li, Alec Wysoker, Tim Fennell et al. · Bioinformatics · 2009 · 67.5K citations · Full text
A map of human genome variation from population-scale sequencing
SIFT: predicting amino acid changes that affect protein function
P.C. Ng · Nucleic Acids Research · 2003 · 6.9K citations · Full text
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Bernard J. Gersh, Barry J. Maron, Robert O. Bonow et al. · Circulation · 2011 · 2.1K citations · Full text